Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4, Open-Label Study in Patients From Asia With Gastroesophageal Reflux Disease Treated With Dexlansoprazole

NCT02351960 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT02351960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02351960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4, Open-Label Study in Patients From Asia With Gastroesophageal Reflux Disease Treated With Dexlansoprazole
Lead sponsor
Takeda
Phase
Phase 4
Overall status
Completed
Start date
March 19, 2015
Completion date
July 13, 2016
Enrollment
296 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal reflux disease